DDMODEL00000229
|
A model for monoclonal antibody-based targeted therapy of Gemtuzumab Ozogamicin (GO) for acute myeloid leukemia (AML)
|
PharmML |
Moran Optimata |
2016/10/26 |
2016/11/01 |
|
DDMODEL00000230
|
A pharmacokinetic model for interleukin-21 therapy validated prospectively in murine experiments in melanoma
|
PharmML |
Moran Optimata |
2016/10/26 |
2016/11/01 |
|
DDMODEL00000125
|
ACTH_Cortisol_Circadian_Rhythm
|
Original code |
Mats Karlsson |
2015/12/13 |
2016/10/21 |
|
DDMODEL00000123
|
AitOudhia_2012_CRP_canakinumab
|
PharmML 0.8.x |
Paolo Magni |
2015/12/12 |
2016/10/13 |
|
DDMODEL00000228
|
Alskär 2015 Gastric emptying and glucose absorption model
|
Original code |
Oskar Alskär |
2016/10/17 |
2016/10/17 |
|
DDMODEL00000284
|
Bajaj_2017_PK_Nivolumab
|
Original code |
Andre Jackson |
2018/03/26 |
2018/04/04 |
|
DDMODEL00000119
|
Bender_2012_thrombocytopenia_TDM1
|
PharmML 0.8.x |
Paolo Magni |
2015/12/12 |
2016/10/13 |
|
DDMODEL00000087
|
Benson 2014 - FAAH Inhibitors Systems Pharmacology Model for Pain
|
PharmML |
Phylinda Chan |
2015/12/10 |
2016/05/25 |
|
DDMODEL00000197
|
Biomarker model for Sunitinib Treatment in GIST
|
Original code |
Sreenath M Krishnan |
2016/06/03 |
2016/06/03 |
|
DDMODEL00000127
|
Bueno_PreclinicalBiomarkerTGI
|
PharmML |
Niklas Hartung |
2015/12/14 |
2016/07/15 |
|
DDMODEL00000078
|
Chalret_2014_Abexinostat
|
PharmML |
Vincent Croixmarie |
2015/12/09 |
2016/02/12 |
|
DDMODEL00000089
|
Chan 2010 - HIV PKPD Viral Load Model
|
PharmML |
Phylinda Chan |
2015/12/10 |
2016/05/25 |
|
DDMODEL00000108
|
Chen’s exocytosis model
|
PharmML |
Roberto Bizzotto |
2015/12/11 |
2016/05/18 |
|
DDMODEL00000090
|
Claret_2009_oncology_capecitabine_TGI
|
PharmML |
Nadia Terranova |
2015/12/10 |
2016/07/13 |
|
DDMODEL00000045
|
Clinical Rifampicin PKPD Model using the Multistate Tuberculosis Pharmacometric Model
|
Original code |
Robin Svensson |
2015/11/30 |
2016/05/25 |
|
DDMODEL00000239
|
Daily and aggregated seizure counts model for scaling from adults to children in epilepsy
|
Original code |
Rik Schoemaker |
2017/05/03 |
2017/05/15 |
|
DDMODEL00000007
|
DelBene_2009_oncology_in_vitro
|
PharmML 0.8.x |
Paolo Magni |
2014/09/25 |
2016/10/10 |
|
DDMODEL00000004
|
DeWinter_2006_diabetes
|
PharmML 0.8.x |
Paolo Magni |
2014/09/25 |
2016/10/10 |
|
DDMODEL00000131
|
Dose-response characteristics of insulin action on glucose metabolism
|
PharmML |
Roberto Bizzotto |
2015/12/29 |
2016/05/18 |
|
DDMODEL00000036
|
Executable_BDQ_M2_PK_DDI_with_LPV-RTV
|
Original code |
Elin Svensson |
2015/11/30 |
2016/06/01 |
|
DDMODEL00000219
|
Executable_BDQ_M2_PK_plus_WT_ALB_in_MDR-TB_patients
|
Original code |
Elin Svensson |
2016/10/10 |
2016/10/10 |
|
DDMODEL00000295
|
Executable_CMS_colistin_PK_CRRT
|
Original code |
Thierry Buclin |
2018/11/13 |
2018/11/13 |
|
DDMODEL00000130
|
Executable_CMS_colistin_PK_v2
|
Original code |
Lena Friberg |
2015/12/18 |
2016/08/27 |
|
DDMODEL00000173
|
Executable_ColistinMeropenem_Interaction
|
Original code |
Bruna Torres |
2016/02/19 |
2016/10/10 |
|
DDMODEL00000214
|
Executable_HFSmodel
|
Original code |
Maria Luisa Sardu |
2016/09/26 |
2016/10/04 |
|
DDMODEL00000285
|
Executable_Laouenant_2015_CPTPSP_hb_RBV
|
Original code |
Julie Bertrand |
2018/05/04 |
2018/05/16 |
|
DDMODEL00000215
|
Executable_Pimasertib_AeDropout
|
Original code |
Maria Luisa Sardu |
2016/09/27 |
2016/10/04 |
|
DDMODEL00000290
|
Executable_simulated_CPathAD
|
Original code |
Daniela Conrado |
2018/05/29 |
2018/05/30 |
|
DDMODEL00000304
|
Executable_Simulated_FluconazolePretermInfantPBPK
|
Original code |
Jacqueline Gerhart |
2019/09/29 |
2019/10/29 |
|
DDMODEL00000298
|
Executable_sultiame_nonlinear_PK
|
Original code |
Kim Dao |
2019/02/28 |
2019/10/18 |
|
DDMODEL00000186
|
Friberg_2002_Oncology_Paclitaxel_Myelosuppression
|
PharmML |
Zinnia Parra-Guillen |
2016/05/17 |
2016/08/24 |
|
DDMODEL00000002
|
Friberg_2009_Schizophrenia_Asenapine_PANSS
|
PharmML |
Zinnia Parra-Guillen |
2014/09/24 |
2016/05/18 |
|
DDMODEL00000001
|
Friberg_2009_Schizophrenia_Prolactin
|
PharmML |
Zinnia Parra-Guillen |
2014/09/24 |
2016/05/24 |
|
DDMODEL00000116
|
Friedrich_2014_HDL
|
PharmML 0.8.x |
Paolo Magni |
2015/12/12 |
2016/10/13 |
|
DDMODEL00000117
|
Friedrich_2014_LDL
|
PharmML 0.8.x |
Paolo Magni |
2015/12/12 |
2016/10/13 |
|
DDMODEL00000118
|
Friedrich_2014_PK
|
PharmML 0.8.x |
Paolo Magni |
2015/12/12 |
2016/10/13 |
|
DDMODEL00000040
|
Furosemide PK with transit compartment absorption
|
Original code |
Rikard Nordgren |
2015/11/30 |
2016/06/03 |
|
DDMODEL00000299
|
Garnett_2018_WhitePaper_QTcF
|
Original code |
Celine Sarr |
2019/03/29 |
2019/03/29 |
|
DDMODEL00000107
|
Girard_2013_oncology_cetuximab_TGI
|
PharmML |
Nadia Terranova |
2015/12/11 |
2016/07/22 |
|
DDMODEL00000227
|
Glucose kinetics in humans: a unique model for different tests
|
PharmML 0.8.x |
Roberto Bizzotto |
2016/10/14 |
2017/06/30 |
|
DDMODEL00000003
|
Hamren_2008_diabetes_tesaglitazar
|
PharmML 0.8.x |
Paolo Magni |
2014/09/25 |
2016/10/10 |
|
DDMODEL00000222
|
Hansson_2013_Fatigue_GIST
|
Original code |
Pierrillas Philippe |
2016/10/11 |
2016/10/12 |
|
DDMODEL00000120
|
Hansson_2013_hypertension_sunitinib
|
PharmML 0.8.x |
Paolo Magni |
2015/12/12 |
2016/10/10 |
|
DDMODEL00000322
|
HCQ popPK model
|
Original code |
Pauline THEMANS |
2020/05/09 |
2020/08/20 |
|
DDMODEL00000098
|
Holford 2008 diabetes progression
|
Original code |
Nick Holford |
2015/12/11 |
2015/12/14 |
|
DDMODEL00000094
|
Insulin sensitivity from labeled IVGTT
|
PharmML |
Roberto Bizzotto |
2015/12/10 |
2016/05/18 |
|
DDMODEL00000058
|
Integrated gastric emptying and bile release model
|
Original code |
Benjamin Guiastrennec |
2015/11/30 |
2015/12/16 |
|
DDMODEL00000039
|
IVGTT Integrated glucose insulin modeI (IGI)
|
Original code |
Moustafa Ibrahim |
2015/11/30 |
2016/06/03 |
|
DDMODEL00000220
|
Jonsson_2011_ethambutol_pharmacokinetics
|
Original code |
Siv Jonsson |
2016/10/11 |
2016/10/12 |
|
DDMODEL00000224
|
Kloft_2006_myelosuppression_docetaxel
|
Original code |
Ida Netterberg |
2016/10/12 |
2016/10/13 |
|